Professor and Chairman, Department of Oncology & Director, University Hospital Cancer Center, University of Zurich, Zurich/Switzerland

Roger Stupp gained his MD at the University of Zurich. After training in oncology and hematology at the University of Chicago he spent 17 years as a physician and researcher at the University of Lausanne, Switzerland. Since 2013 he is the Director of the Department of Oncology and Cancer Center at the University Hospital in Zurich. He also serves as the President of the European Organisation for Research and Treatment of Cancer (EORTC), the prime cooperative group conducting clinical trials and translational research throughout a pan-European network of over 200 active universities and academic medical centers. Dr. Stupp's research focuses on early drug development, the combination of chemo- and radiotherapy, multidisciplinary cancer management, namely in the areas of lung cancer and brain tumors. He is involved in bringing new antiangiogenic and biological treatments to the clinic. Dr. Stupp is or has been the principal investigator for large multimodality clinical trials in brain tumors and non-small cell lung cancer. His work has been extensively published in such journals as The New England Journal of Medicine, Lancet Oncology, Clinical Cancer Research, Molecular Oncology, Neuro-Oncology, the European Journal of Cancer, and the Journal of Clinical Oncology, among others.

Dr. Stupp is associate and section editor for the European Journal of Cancer, and is a member of the editorial board of several oncology journals. He also serves in scientific or educational committees of the European Society of Medical Oncology (ESMO) and the American Society of Clinical Oncology (ASCO); he also acts as a council for several European and National funding agencies.

Dr. Stupp has received several awards, most recently  the Victor Levin Award by the Society of Neuro-Oncology in the USA, and the Hamilton Fairley Award by the European Society of Medical Oncology in 2013.